LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mechanism of the Valveless Pump Revealed in Online Video Presentation

By LabMedica International staff writers
Posted on 16 Dec 2014
Image: The QG line of pumps is ideal for general laboratory and industrial use (Photo courtesy of Fluid Metering, Inc.).
Image: The QG line of pumps is ideal for general laboratory and industrial use (Photo courtesy of Fluid Metering, Inc.).
The secrets behind a precision valveless pump used in both research and clinical instruments and processes have been revealed in a high definition video presentation.

Fluid Metering, Inc. (New York, USA) is a metering pumps and dispensers manufacturer, who pioneered the first patented valveless rotating and reciprocating piston metering pump concept and has been producing instruments for precise fluid control for over 55 years.

The Fluid Metering, Inc. CeramPump design utilizes a single, dimensionally stable, chemically inert ceramic piston that ensures long term, drift free fluid control. The valveless pumping function is accomplished by the synchronous rotation and reciprocation of the ceramic piston in a precisely mated ceramic cylinder liner. One complete piston revolution is required for each suction/discharge cycle. The flow rate, which can be changed while pump is operating or at rest, is easily adjusted between 0%–100% by moving the pump head position, which changes the piston stroke length and, in turn, the flow rate.

As described in a recently released on-line video presentation, the CeramPump relies on only one moving part, a rotating and reciprocating ceramic piston, to accomplish all fluid control functions without valves and will maintain a precision of 0.5% for millions of cycles without calibration or maintenance.

Related Links:
Fluid Metering, Inc.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)

Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more